Clinical analysis on adverse reactions of anti-TB drugs and evaluation on curative effect of leucopenia
10.3969/j.issn.1671-8348.2017.16.014
- VernacularTitle:抗结核药物不良反应的临床分析及白细胞下降治疗效果评价
- Author:
Dingyuan LIU
;
Hu LUO
;
Xiangdong ZHOU
- Keywords:
tuberculosis;
leucopenia;
clinical analysis;
curative efficacy
- From:
Chongqing Medicine
2017;46(16):2206-2208
- CountryChina
- Language:Chinese
-
Abstract:
Objective To statistically summarize the adverse reactions of anti-TB drugs treatment,to analyze the influencing factors of leucopenia and to compare the effect of Qijiao Shengbai Capsule and Leucogen Tablet in the treatment of leucopenia.Methods The adverse reactions in 840 TB patients diagnosed from September 2014 to November 2015 were statistically analyzed.The influencing factors of leucopenia were analyzed.Finally,the effect of Qijiao Shengbai Capsule(n=480) and Leucogen Tablets (n=360) for treating leucopenia.Results Clinicians paid less attention to routine blood monitoring (39.4 ％).Among adverse reactions,the damage of liver function had the highest incidence rate(abnormal liver enzymes 27.0％,increased bile acid 8.2％),followed by leukopenia [25.4％,mainly degree Ⅰ (16.9％)];female patients(P=0.000) and complicating liver damage(P=0.010) might be the risk factors of leukopenia.After treatment by two kinds of drug,white blood cells count was increased,the difference was statistically significant(P=0.000).Conclusion The occurrence rate of leucopenia is higher,females and liver function damage are easier to appear,so more attention should be paid to monitoring the blood routine in return visit.The two kinds of drug for treating leucopenia induced by anti-TB drugs have definite effect and could be used in clinic.
